Differential cellular effects of sunitinib and pazopanib targeted drugs for metastatic renal cell carcinoma: an in vitro approach. RevSALUS [Internet]. 6 de Abril de 2022 [citado 25 de Junho de 2026];4(Sup):167-8. Disponível em: https://revsalus.com/index.php/RevSALUS/article/view/401